[Recurrent aphthosis: safety of low dose thalidomide].
Thalidomide is an effective treatment for recurrent aphthosis but its effectiveness at low dose has been rarely assessed. Single-centre non-randomized retrospective open study. Forty-seven patients were treated with thalidomide for recurrent aphthosis (41 patients) or Behçet disease (six patients). Remission was obtained with a dose of 25 mg daily. Discontinuation of treatment for side effects was not observed in this case series. Low dose thalidomide below 50 mg daily is an effective and well tolerated treatment of aphthosis.